ATTENTION/WARNING - NE PAS DÉPOSER ICI/DO NOT SUBMIT HERE

Ceci est la version de TEST de DIAL.mem. Veuillez ne pas soumettre votre mémoire sur ce site mais bien à l'URL suivante: 'https://thesis.dial.uclouvain.be'.
This is the TEST version of DIAL.mem. Please use the following URL to submit your master thesis: 'https://thesis.dial.uclouvain.be'.
 

Inventory and distribution management under a pandemic: the case of pharmaceuticals during COVID-19

Deramoudt, Robin
(2023)

Files

Deramoudt_16251800_2023.pdf
  • Closed access
  • Adobe PDF
  • 1.67 MB

Details

Supervisors
Agrell, Per Joakim
Faculty
Louvain School of Management
Degree label
Master [120] : ingénieur de gestion, à finalité spécialisée
Abstract
The recent COVID-19 pandemic has shaken the entire world without exception. Pharmaceutical companies, the mainstays of this crisis and of the vaccine race, have of course been no exception. Their supply chains have been put to the test and have had to adapt to this crisis. In this thesis, we focus specifically on the impact of the pandemic on pharmaceutical companies inventory management and distribution. To do so, we use all available literature and data on the subject before comparing them with their equivalents at GlaxoSmithKline (GSK). The quantitative and qualitative impacts of the pandemic are analyzed, and we attempt to determine the main consequences of the pandemic for pharmaceutical companies. Our observations lead to the conclusion that COVID-19 and the scientific advances arising from the vaccine race will optimize inventory management and agility, but also that the future of pharmaceutical distribution lies in the development of shipping and regional distribution centers around the world.